AIMMUNE THERAPEUTICS, INC.: common_shares_outstanding

Value{"unit": "shares", "value": 58651000, "concept": "us-gaap:CommonStockSharesOutstanding"}
Period (as of 2018-09-30)
Statuscurrent
EntityAIMMUNE THERAPEUTICS, INC.
Provenance
Source: SEC EDGAR CompanyFacts (US-PD-17USC105)
Reference: 0001564590-18-028572 · Open the official SEC filing →
Retrieved: 2026-08-19T16:46:43.812497+02:00
Raw response sha256: f7bde1a401b286c74a2fd824ee1df541…
Also addressable by official identifiers: https://factanker.com/fact/sec/cik-0001631650/common-shares-outstanding/2018-09-30 (CIK, metric, reporting date)
Cite as: FACTANKER, https://factanker.com/fact/3fa5bf4d-de53-43fa-9715-250b14461539

History

From the Record
32 US software companies haven’t lost money in a decade. One of them is steadier than all the rest.
Read the findingSearch 53 million companies